Table 3 Results of an EP-15 analytical imprecision verification of both the RMP and the DCM
Sample | Peptide | Average (nmol/L) | CV wr (%) | CV br (%) | CV wl (%) | TEa (%) |
|---|---|---|---|---|---|---|
Reference Measurement Procedure* | ||||||
1 | GISSTVTGR | 42.9 | 7.7 | 4.6 | 9.0 | 11.9 |
2 | GISSTVTGR | 7.4 | 14.4 | 13.6 | 19.8 | 18.7 |
3 | GISSTVTGR | 13.6 | 10.3 | 6.3 | 12.1 | 15.8 |
4 | GISSTVTGR | 234 | 8.1 | 6.7 | 10.5 | 8.4 |
5 | GISSTVTGR | 292 | 7 | 4.0 | 8.1 | 7.8 |
1 | LFLEPTQADIALLK | 46.7 | 7.3 | 5.0 | 8.9 | 11.9 |
2 | LFLEPTQADIALLK | 8 | 5.8 | 5.0 | 7.7 | 18.7 |
3 | LFLEPTQADIALLK | 14.9 | 8.8 | 6.5 | 10.9 | 15.8 |
4 | LFLEPTQADIALLK | 238 | 7.7 | 3.5 | 8.4 | 8.4 |
5 | LFLEPTQADIALLK | 344 | 6.6 | 5.7 | 8.7 | 7.8 |
Designated Comparison Method | ||||||
1 | GISSTVTGR | 4 | 29.7 | 0.0 | 29.7 | 21.3 |
2 | GISSTVTGR | 6 | 25.6 | 9.9 | 28.0 | 20.3 |
3 | GISSTVTGR | 7 | 19.6 | 0.0 | 19.6 | 18.7 |
4 | GISSTVTGR | 94 | 9.3 | 0.0 | 9.3 | 10 |
5 | GISSTVTGR | 55 | 13.5 | 0.0 | 13.5 | 11.3 |
1 | LFLEPTQADIALLK | 5 | 14.8 | 4.3 | 15.4 | 21.3 |
2 | LFLEPTQADIALLK | 6 | 13.8 | 0.0 | 13.8 | 20.3 |
3 | LFLEPTQADIALLK | 8 | 12.1 | 1.3 | 12.2 | 18.7 |
4 | LFLEPTQADIALLK | 102 | 5.9 | 3.7 | 7.0 | 10 |
5 | LFLEPTQADIALLK | 59 | 5.6 | 4.6 | 7.3 | 11.3 |